GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Indies Pharma Jamaica Ltd (XJAM:INDIES) » Definitions » Gross-Profit-to-Asset %

Indies Pharma Jamaica (XJAM:INDIES) Gross-Profit-to-Asset % : 0.00% (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Indies Pharma Jamaica Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Indies Pharma Jamaica's annualized Gross Profit for the quarter that ended in . 20 was JMD Mil. Indies Pharma Jamaica's average Total Assets over the quarter that ended in . 20 was JMD 0 Mil. Therefore, Indies Pharma Jamaica's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.


Indies Pharma Jamaica Gross-Profit-to-Asset % Historical Data

The historical data trend for Indies Pharma Jamaica's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indies Pharma Jamaica Gross-Profit-to-Asset % Chart

Indies Pharma Jamaica Annual Data
Trend
Gross-Profit-to-Asset %

Indies Pharma Jamaica Semi-Annual Data
Gross-Profit-to-Asset %

Competitive Comparison of Indies Pharma Jamaica's Gross-Profit-to-Asset %

For the Medical Distribution subindustry, Indies Pharma Jamaica's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indies Pharma Jamaica's Gross-Profit-to-Asset % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Indies Pharma Jamaica's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Indies Pharma Jamaica's Gross-Profit-to-Asset % falls into.


;
;

Indies Pharma Jamaica Gross-Profit-to-Asset % Calculation

Indies Pharma Jamaica's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Indies Pharma Jamaica's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Indies Pharma Jamaica Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Indies Pharma Jamaica's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Indies Pharma Jamaica Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1a Pimento Way, Freeport, Montego Bay, St. James, JAM
Indies Pharma Jamaica Ltd offers marketing and distribution services to its overseas pharmaceutical manufacturers. The company products include Anti-Hypertensive, Anti-Thrombolytic, Microcirculation Agent, Anti-Cholesterol, and others.

Indies Pharma Jamaica Headlines

No Headlines